The ulinastatin group had lower incidence of new-onset organ failure ( @ vs. @ patients , p = @ ) , more ventilator-free days ( mean SD @ @ days vs. @ @ days , p = @ ) , and shorter hospital stay ( @ @ days vs. @ @ days , p < @ ) .